Fluxergy

Fluxergy is a private, commercial-stage diagnostics company based in Heidelberg, Germany, founded in 2014. Its core innovation is the Fluxergy Analyzer, a versatile POC platform capable of running multiplexed molecular (PCR), immunoassay, cytometry, and electrochemistry tests from a single device with results in about an hour. The company targets decentralized testing markets, including human clinical, veterinary, and potentially public health, with an open platform strategy that allows for the development of a wide range of assays by partners and the company itself. Fluxergy appears to be in an early revenue phase, having manufactured significant quantities of test systems and cartridges.

Integrated, multimodal point-of-care diagnostic platform combining molecular (PCR), immunochemistry, cytometry, and electrochemistry detection on a single benchtop analyzer and disposable test card.

Fluxergy competes in the crowded POC diagnostics market against large diversified players (Abbott, Roche, Siemens) and focused molecular diagnostics companies (Cepheid, BioFire). Its differentiation lies in combining multiple diagnostic modalities on a single, open platform, a claim not commonly made by existing competitors who often offer dedicated systems for each test type.